Medicine and Dentistry

1. Patient 100%
2. Acute B-Cell Lymphoblastic Leukemia 85%
3. Toxicity 85%
4. Cells 71%
5. B Cell 70%
6. Therapeutic Procedure 64%
7. T Cell 53%
8. Chimeric Antigen Receptor T-Cell 51%
9. Granulocyte Macrophage Colony Stimulating Factor 42%
10. Young Adult 42%
11. Adult 42%
12. Pediatrics 42%
13. Chimeric Antigen Receptor 42%
14. Graft Versus Leukemia Effect 42%
15. Acute Lymphoblastic Leukemia 42%
16. Event Free Survival 38%
17. Spontaneous Remission 38%
18. Bone Marrow 30%
19. Wilms' Tumor 28%
20. Tumor Protein 28%
21. Synapsin I 28%
22. Differentiation 28%
23. Aplasia 27%
24. Adverse Event 25%
25. Minimal Residual Disease 25%
26. Incidence 19%
27. Cytokine Release Syndrome 19%
28. Allogeneic Stem Cell Transplantation 17%
29. Age 17%
30. Acute Myeloid Leukemia 14%
31. Clinical Trial 14%
32. Cord Blood 14%
33. Identity 14%
34. Lentivirus Vector 14%
35. Human Leukocyte Antigen 14%
36. B Cell Development 14%
37. Maturation 14%
38. Leukemia Antigen 14%
39. T Cell Development 14%
40. Allogeneic Hematopoietic Stem Cell Transplantation 14%
41. Hematopoietic Stem Cell Transplantation 14%
42. Morphology 10%
43. Survival Rate 10%
44. Chimeric Antigen Receptor T-Cell Immunotherapy 10%
45. down Regulation 10%
46. Hypogammaglobulinemia 8%
47. Therapeutics 8%
48. Prognosis 8%
49. Engraftment 8%
50. Follow up 8%